Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
Search for other papers by Feng Gu in
Google Scholar
PubMed
Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Search for other papers by Thierry C Brue in
Google Scholar
PubMed
Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
Search for other papers by Ilan Shimon in
Google Scholar
PubMed
Search for other papers by Aart J van der Lely in
Google Scholar
PubMed
Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed
Search for other papers by Albert Kandra in
Google Scholar
PubMed
Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed
Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed
lanreotide, except for the frequency and degree of hyperglycemia. Pasireotide binds with high affinity to four of the five somatostatin receptor subtypes (SST): SST 1 , SST 2 , SST 3 and SST 5 ( 14 ), with highest affinity for SST 5 (39-fold higher
The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Search for other papers by Chunliang Yang in
Google Scholar
PubMed
Search for other papers by Junyi Li in
Google Scholar
PubMed
Search for other papers by Fei Sun in
Google Scholar
PubMed
Search for other papers by Haifeng Zhou in
Google Scholar
PubMed
Search for other papers by Jia Yang in
Google Scholar
PubMed
Search for other papers by Chao Yang in
Google Scholar
PubMed
Introduction Hyperglycemia, the leading indicator of diabetes, refers to a pathological state with abnormally high blood glucose level. Hyperglycemia can be a consequence of either impaired insulin secretion arising from the loss of pancreatic
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Jairo Arturo Pinzón-Cortés in
Google Scholar
PubMed
Search for other papers by Angelina Perna-Chaux in
Google Scholar
PubMed
Search for other papers by Nicolás Steven Rojas-Villamizar in
Google Scholar
PubMed
Search for other papers by Angélica Díaz-Basabe in
Google Scholar
PubMed
Search for other papers by Diana Carolina Polanía-Villanueva in
Google Scholar
PubMed
Search for other papers by María Fernanda Jácome in
Google Scholar
PubMed
Endocrinology Section, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
Search for other papers by Carlos Olimpo Mendivil in
Google Scholar
PubMed
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Helena Groot in
Google Scholar
PubMed
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Valeriano López-Segura in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is a complex disease characterized by hyperglycemia secondary to inappropriate insulin secretion, resistance to its action, or both. Over time, these alterations and oxidative stress promote the
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed
Search for other papers by Luigi Maione in
Google Scholar
PubMed
Search for other papers by Sylvie Salenave in
Google Scholar
PubMed
Search for other papers by Jacques Young in
Google Scholar
PubMed
Search for other papers by Peter Kamenický in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
of the development of hyperglycemia might be important for the choice of antidiabetic treatment. The aim of this study was therefore to evaluate longitudinal changes in glucose homeostasis in detail in a real-life cohort of patients with acromegaly
Search for other papers by Justyna Modrzynska in
Google Scholar
PubMed
Search for other papers by Christine F Klein in
Google Scholar
PubMed
Search for other papers by Kasper Iversen in
Google Scholar
PubMed
Search for other papers by Henning Bundgaard in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
Search for other papers by Maike Mose in
Google Scholar
PubMed
Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed
Search for other papers by Niels Møller in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai J Wewer Albrechtsen in
Google Scholar
PubMed
patients, independent of pre-existing disturbances in glucose metabolism ( 8 , 9 ), and hyperglycemia is significantly associated with their increased mortality ( 10 ). Some studies have reported that glucagon and GLP-1 concentrations are elevated during
Search for other papers by Jared G Friedman in
Google Scholar
PubMed
Search for other papers by Kasey Coyne in
Google Scholar
PubMed
Search for other papers by Grazia Aleppo in
Google Scholar
PubMed
Search for other papers by Emily D Szmuilowicz in
Google Scholar
PubMed
of average glycemia over months and as such does not provide actionable information regarding glucose patterns over the day, glucose variability, or the amount of time spent in the hyperglycemia, hypoglycemia, and target ranges or hypoglycemia ( 6
Search for other papers by Hoda Gad in
Google Scholar
PubMed
Search for other papers by Einas Elgassim in
Google Scholar
PubMed
Department of Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
Search for other papers by Ibrahim Mohammed in
Google Scholar
PubMed
Search for other papers by Ahmad Yaser Alhaddad in
Google Scholar
PubMed
Search for other papers by Hussein Ahmed Hussein Zaky Aly in
Google Scholar
PubMed
Search for other papers by John-John Cabibihan in
Google Scholar
PubMed
Search for other papers by Abdulaziz Al-Ali in
Google Scholar
PubMed
Search for other papers by Kishor Kumar Sadasivuni in
Google Scholar
PubMed
Search for other papers by Aliyaa Haji in
Google Scholar
PubMed
Search for other papers by Neila Lamine in
Google Scholar
PubMed
Search for other papers by Adnan Khan in
Google Scholar
PubMed
Search for other papers by Ioannis N Petropoulos in
Google Scholar
PubMed
Search for other papers by Georgios Ponirakis in
Google Scholar
PubMed
Search for other papers by Alise Kalteniece in
Google Scholar
PubMed
Search for other papers by Maryam Ferdousi in
Google Scholar
PubMed
Search for other papers by Shazli Azmi in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK
Division of Endocrinology, Diabetes and Gastroenterology, University of Manchester, Manchester, UK
Search for other papers by Uazman Alam in
Google Scholar
PubMed
Search for other papers by Wajeeha Abuhelaiqa in
Google Scholar
PubMed
Search for other papers by Amin Jayyousi in
Google Scholar
PubMed
Search for other papers by Dabia AlMohanadi in
Google Scholar
PubMed
Search for other papers by Khaled Baagar in
Google Scholar
PubMed
Institute of Cardiovascular Medicine, University of Manchester, Manchester, UK
Search for other papers by Rayaz A Malik in
Google Scholar
PubMed
hyperglycemia) and TAR >250 mg/dL was <5% of the readings (1 h 12 min) (level 2 hyperglycemia). Glycemic variability (GV) was defined as percent CV with a target ≤36%. Hypoglycemia was defined according to continuous glucose reading of <70 mg/dL. Corneal
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Qiankai Jin in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Guoqing Huang in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Xiaoqing Tian in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Yimeng Shu in
Google Scholar
PubMed
School of Medicine, Ningbo University, Ningbo, China
Search for other papers by Ximisinuer Tusongtuoheti in
Google Scholar
PubMed
Search for other papers by Yushan Mao in
Google Scholar
PubMed
, hypertriglyceridemia, hyperglycemia, and low high-density lipoprotein cholesterol (HDL-C)). Although not a specific disease, MetS is a complex pathophysiologic state in which multiple risk factors converge to add the risk of many familiar diseases ( 2 ). With the
Search for other papers by Aldo Bonaventura in
Google Scholar
PubMed
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Search for other papers by Fabrizio Montecucco in
Google Scholar
PubMed
Search for other papers by Franco Dallegri in
Google Scholar
PubMed
patients to identify hypoglycemia and hyperglycemia and get immediate feedback about the effect of food choices, stress, activity, and insulin dosing on glucose levels. In addition, patients can better determine, together with clinicians, if a medication
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Nektaria Papadopoulou-Marketou in
Google Scholar
PubMed
Search for other papers by George P Chrousos in
Google Scholar
PubMed
Search for other papers by Christina Kanaka-Gantenbein in
Google Scholar
PubMed
lymphocytes and dendritic cells. This condition usually evolves over many months or years, when patients are asymptomatic and euglycemic. Symptomatic hyperglycemia occurs after a long latency period, which reflects the large number of functioning β cells that